Greater Glasgow and Clyde Medicines
Key to symbols The medicine should be initiated by, or on the advice of a specialist, but is suitable for continuation by a GP The medicine should only be used and prescribed by a specialist Indicates the preferred choice within a class or group of medicines
The medicine should be initiated by, or on the advice of a specialist, but is suitable for continuation by a GP
The medicine should only be used and prescribed by a specialist
Indicates the preferred choice within a class or group of medicines
3. Respiratory system

3.3. Cromoglicate and related therapy, leukotriene receptor antagonists, and phosphodiesterase type-4 inh

3.3.1. Cromoglicate and related therapy

3.3.2. Leukotriene receptor antagonists

Preferred List
MONTELUKAST

Restrictions:

Use for seasonal allergic rhinitis was not accepted by SMC and this indication is non-Formulary.

 

The MHRA has issued advise for healthcare professionals regarding risks of neuropsychiatric reactions for montelukast. For further information click here.

 

Prescribing Notes:

Not currently licensed for use in COPD

BNF Link

3.3.3. Phosphodiesterase type-4 inhibitors